Michael Olson

831 total citations
26 papers, 441 citations indexed

About

Michael Olson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Michael Olson has authored 26 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Michael Olson's work include CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Michael Olson is often cited by papers focused on CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Michael Olson collaborates with scholars based in United States, Canada and China. Michael Olson's co-authors include Tim Luetkens, Djordje Atanackovic, Halli E. Miller, Wenwen Xu, Li Wang, Subramaniam Malarkannan, Kamalakannan Rajasekaran, Ying Yuan, Marc S. Ernstoff and Juan Dong and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Michael Olson

24 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Olson United States 10 268 267 83 59 38 26 441
Chikara Takahashi United States 8 568 2.1× 324 1.2× 153 1.8× 39 0.7× 21 0.6× 13 779
Kevin Laubscher United States 10 94 0.4× 189 0.7× 152 1.8× 58 1.0× 25 0.7× 18 436
Rohan P. Joshi United States 10 191 0.7× 166 0.6× 151 1.8× 32 0.5× 9 0.2× 27 469
William N. Bell United States 7 166 0.6× 181 0.7× 132 1.6× 37 0.6× 19 0.5× 8 323
Karen Chagin United States 9 105 0.4× 181 0.7× 58 0.7× 67 1.1× 150 3.9× 17 345
Linus Angenendt Germany 11 103 0.4× 204 0.8× 173 2.1× 25 0.4× 104 2.7× 29 404
Candy Garcia United States 3 207 0.8× 393 1.5× 81 1.0× 101 1.7× 7 0.2× 3 484
Jakob Kaeppler United Kingdom 8 121 0.5× 103 0.4× 113 1.4× 48 0.8× 13 0.3× 11 337
Jessica D. Weaver United States 6 377 1.4× 302 1.1× 106 1.3× 32 0.5× 10 0.3× 9 514
Paola Dama United Kingdom 9 118 0.4× 180 0.7× 223 2.7× 21 0.4× 61 1.6× 18 448

Countries citing papers authored by Michael Olson

Since Specialization
Citations

This map shows the geographic impact of Michael Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Olson more than expected).

Fields of papers citing papers by Michael Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Olson. The network helps show where Michael Olson may publish in the future.

Co-authorship network of co-authors of Michael Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Olson. A scholar is included among the top collaborators of Michael Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Olson. Michael Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korell, Felix, Michael Olson, Diego Salas‐Benito, et al.. (2024). Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics. Science Translational Medicine. 16(750). eadk7640–eadk7640. 14 indexed citations
2.
Mause, Erica R. Vander, Jillian M. Baker, Sabarinath Venniyil Radhakrishnan, et al.. (2023). Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Science Translational Medicine. 15(705). eadd7900–eadd7900. 17 indexed citations
3.
Pourzia, Alexandra L., Michael Olson, Stefanie R. Bailey, et al.. (2023). Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells. Cell Death and Disease. 14(4). 267–267. 9 indexed citations
4.
Korell, Felix, Michael Olson, Diego Salas‐Benito, et al.. (2023). Abstract 4098: Chimeric antigen receptor (CAR) T cells overexpressing Bcl-xL increase proliferation and antitumor activity alone and in combination with BH3 mimetics. Cancer Research. 83(7_Supplement). 4098–4098. 3 indexed citations
5.
Pourzia, Alexandra L., et al.. (2022). 269 Mitochondrial apoptosis mediates CAR T cell cytotoxicity. Regular and Young Investigator Award Abstracts. A284–A284. 1 indexed citations
6.
Olson, Michael, Tim Luetkens, Sabarinath Venniyil Radhakrishnan, et al.. (2021). CD229 CAR T Cell Therapy for the Treatment of Relapsed B Cell Lymphoma. Blood. 138(Supplement 1). 2800–2800. 1 indexed citations
7.
Olson, Michael, Tim Luetkens, & Djordje Atanackovic. (2021). CD19 loss by CAR T cell mediated trogoctyosis is regulated by CAR affinity. The Journal of Immunology. 206(1_Supplement). 58.03–58.03. 1 indexed citations
8.
Radhakrishnan, Sabarinath Venniyil, Tim Luetkens, Sandra D. Scherer, et al.. (2020). CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Nature Communications. 11(1). 798–798. 57 indexed citations
9.
Xu, Wenwen, Juan Dong, Yongwei Zheng, et al.. (2019). Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell–Mediated Inflammation and Immunosuppression. Cancer Immunology Research. 7(9). 1497–1510. 125 indexed citations
10.
Hendrickson, Peter G., Michael Olson, Tim Luetkens, et al.. (2019). The promise of adoptive cellular immunotherapies in hepatocellular carcinoma. OncoImmunology. 9(1). 1673129–1673129. 31 indexed citations
11.
Olson, Michael, Sabarinath Venniyil Radhakrishnan, Tim Luetkens, & Djordje Atanackovic. (2018). The role of surface molecule CD229 in Multiple Myeloma. Clinical Immunology. 204. 69–73. 12 indexed citations
12.
Li, Na, Wenwen Xu, Ying Yuan, et al.. (2017). Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis. Scientific Reports. 7(1). 1485–1485. 79 indexed citations
13.
Xu, Wenwen, Ying Yuan, Na Li, et al.. (2017). Abstract 2996: Immune checkpoint protein VISTA suppresses Toll-like receptor signaling and the production of inflammatory cytokines. Cancer Research. 77(13_Supplement). 2996–2996. 1 indexed citations
14.
Olson, Michael, et al.. (2004). An automated phase cancellation method for measuring ultra-high third order intercept points. 1727–1730. 3 indexed citations
15.
Olson, Michael, et al.. (2002). Single bridging fault diagnosis for CMOS circuits. 2. 732–735. 2 indexed citations
16.
Yeung, Donald, et al.. (2002). A unified on-line and off-line BIST scheme for ROMs. 469–472.
17.
Olson, Michael. (1975). Superpressure Balloons and Communications Satellites - A New Approach for Tropical Meteorological Soundings. IEEE transactions on geoscience electronics. 13(1). 60–71. 2 indexed citations
18.
Olson, Michael. (1975). False-Lock Detection in Costas Demodulators. IEEE Transactions on Aerospace and Electronic Systems. AES-11(2). 180–182. 11 indexed citations
19.
Passi, Ranjit M. & Michael Olson. (1974). Carrier Balloon Windfinding Subsystem Evaluation. Bulletin of the American Meteorological Society. 55(12). 1463–1470. 2 indexed citations
20.
Olson, Michael. (1973). Barai sentence structure and embedding. Americanae (AECID Library). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chikara Takahashi Breakdown of academic impact, for papers by Kevin Laubscher Breakdown of academic impact, for papers by Rohan P. Joshi Breakdown of academic impact, for papers by William N. Bell Breakdown of academic impact, for papers by Karen Chagin Breakdown of academic impact, for papers by Linus Angenendt Breakdown of academic impact, for papers by Candy Garcia Breakdown of academic impact, for papers by Jakob Kaeppler Breakdown of academic impact, for papers by Jessica D. Weaver Breakdown of academic impact, for papers by Paola Dama
Rankless by CCL
2026